Point-of-Care (POC) Coagulation Testing Devices Market Expansion 2024-2033: Growth Drivers and Dynamics | Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips N.V.

The point-of-care (poc) coagulation testing devices global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Point-of-Care (POC) Coagulation Testing Devices Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The point-of-care (POC) coagulation testing devices market size has grown strongly in recent years. It will grow from $1.93 billion in 2023 to $2.12 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to growing prevalence of infectious and chronic diseases, increasing geriatric population, increasing use of miniaturized portable instruments, growing use of biomarker profiling, and growing demand for personalized medicine.

The point-of-care (POC) coagulation testing devices market size is expected to see strong growth in the next few years. It will grow to $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing emphasis on wellness and preventive healthcare, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and rise of telemedicine. Major trends in the forecast period include next-generation sequencing (NGS) integration, RNA detection and analysis, single-cell PCR analysis, bioinformatics software and data analysis tools, microfluidic technologies, lab-on-a-chip systems, and point-of-care testing (POCT), artificial intelligence (AI) and data analytics.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-devices-global-market-report

Scope Of Point-of-Care (POC) Coagulation Testing Devices Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Point-of-Care (POC) Coagulation Testing Devices Market Overview

Market Drivers –
The rise in the prevalence of blood clotting disorders is expected to propel the growth of the point-of-care (POC) coagulation testing devices market going forward. Blood clotting disorders impair the blood’s ability to clot properly. Lifestyle factors can contribute to blood clotting disorders, including smoking, excessive alcohol consumption, and a sedentary lifestyle. These behaviors can affect blood vessel health, clotting factor levels, and blood flow, increasing the risk of abnormal clot formation. POC coagulation testing devices enable healthcare providers to quickly assess a patient’s coagulation status, allowing for timely adjustments to medication dosages and treatment plans. For instance, in December 2022, according to the annual global survey of 188 countries conducted by the World Federation of Hemophilia, a Canada-based international non-profit organization, in 2021, there were 429,232 individuals affected by bleeding disorders, comprising 256,840 with hemophilia, a genetic disorder characterized by insufficient clotting factors in the blood, 98,293 with von Willebrand disease (VWD), a condition where the blood does not clot effectively, and 74,099 with other bleeding disorders. This marks a 9% rise from the previous year, with hemophilia cases increasing by 6%, von Willebrand disease cases by 12%, and other bleeding disorders by 15%. Therefore, the rise in the prevalence of blood clotting disorders drives the growth of the point-of-care (POC) coagulation testing devices market.

Market Trends –
Major companies operating in the point-of-care (POC) coagulation testing devices market are developing immunofluorescence-based quantitative analyzers to improve the diagnosis and management of coagulation disorders. Immunofluorescence-based quantitative analyzers are diagnostic instruments used in laboratory settings to measure and quantify specific proteins or molecules involved in the coagulation process, aiding in diagnosing and managing blood clotting disorders. For instance, in January 2023, Cipla Limited, an India-based pharmaceutical company, launched Cippoint. This immunofluorescence-based quantitative analyzer utilizes immunofluorescence technology to provide rapid and accurate test results in 3 to 15 minutes, facilitating faster clinical decision-making processes. With its user-friendly interface, quick turnaround time, and comprehensive testing capabilities, Cippoint is crucial in enhancing diagnostic efficiency, enabling timely clinical decisions, and improving patient care outcomes.

The point-of-care (POC) coagulation testing devices market covered in this report is segmented –

1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Blood Gas And Electrolyte Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users

Get an inside scoop of the point-of-care (poc) coagulation testing devices market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15636&type=smp

Regional Insights –
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2023. The regions covered in the point-of-care (POC) coagulation testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the point-of-care (POC) coagulation testing devices market are  Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips N.V., Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, Sonora Quest Laboratories, 23andMe Holding Co, Thorne HealthTech Inc., Metropolis Healthcare Limited, Color Health Inc, LetsGetChecked Inc., Ambry Genetics Corporation, MyHeritage Ltd, Genova Diagnostics Inc., Everlywell Inc., Complete Genomics Incorporated, DanteLabs Inc., HemoSonics LLC, Gene by Gene Ltd., Veritas Intercontinental, DirectLabs LLC, Full Genomes Corporation Inc., Ulta Lab Tests LLC, WellnessFX Inc., Any Lab Test Now Inc.

Table of Contents
1. Executive Summary
2. Point-of-Care (POC) Coagulation Testing Devices Market Report Structure
3. Point-of-Care (POC) Coagulation Testing Devices Market Trends And Strategies
4. Point-of-Care (POC) Coagulation Testing Devices Market – Macro Economic Scenario
5. Point-of-Care (POC) Coagulation Testing Devices Market Size And Growth
…..
27. Point-of-Care (POC) Coagulation Testing Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the trending research reports from TBRC:
https://topprnews.com/global-clinical-nutrition-for-diabetes-care-market/
https://topprnews.com/direct-to-consumer-dtc-laboratory-testing-market-size/
https://topprnews.com/generative-ai-in-chip-design-market-overview/
https://goodprnews.com/clinical-nutrition-for-diabetes-care-market-overview/
https://goodprnews.com/direct-to-consumer-dtc-laboratory-testing-market-outlook/
https://goodprnews.com/global-generative-ai-in-chip-design-market/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model